Recruiting

ERRT

Sponsor:

University of Tulsa

Code:

NCT02236377

Conditions

Frequent Trauma-related Nightmares

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Exposure, Relaxation, and Rescripting Therapy

Study Details

Brief summary:

The purpose of this case series dismantling study is to extend previous findings regarding the efficacy of a brief treatment for chronic post-trauma nightmares by examining the dose effect and mechanism of change.

Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. ERRT has exhibited strong support in reducing the frequency and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. In addition, significant decreases in PTSD and depression symptoms have been reported following treatment (Davis et al., 2011; Davis \& Wright, 2007; Long et al., 2011; Swanson, Favorite, Horin, \& Arnedt, 2009). ERRT is currently an evidence-level B suggested treatment (Cranston, Davis, Rhudy, \& Favorite, 2011).

Despite this evidence, the mechanism of change for ERRT remains unclear. We propose to conduct a set of case series in order to examine the possible mechanisms: psycho-education, dose response for exposure, and no exposure components of the treatment. Each part of the treatment is theorized to contribute to the improved treatment outcome and it is hypothesized that participants will benefit no matter what group they are in. All participants will receive 5 to 6 treatment sessions, conducted once per week for about 90 minutes, of a modified version of ERRT.

Conditions

Frequent Trauma-related Nightmares

Study ID

NCT02236377

Start date

Aug, 2014

Status verified date

Jul, 2024

Completion date

Aug, 2025

Anticipated

Primary completion date

Jul, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 18 years of age or older at the time of the intake,
  • experienced a traumatic event, as defined by the Diagnostic and Statistical Manual (DSM-5),
  • have approximately one nightmare each week for the past month
  • be able to read and speak English.

Exclusion Criteria:

  • age of 17 or younger
  • acute or apparent psychosis
  • unmedicated bipolar disorder
  • intellectual disability
  • active suicidality,
  • recent parasuicidal behaviors
  • untreated substance use disorder in past 6 months

Study Design

Enrollment

50 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: ERRT - Enhanced Exposure

Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced exposure techniques

active comparator: ERRT - Sleep and Relaxation

Exposure, Relaxation, and Rescripting Therapy protocol, 5 sessions, focused on sleep and relaxation

active comparator: ERRT-Rescription

Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with rescription but no exposure

active comparator: ERRT-Sleep

Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced sleep techniques

active comparator: ERRT - Consensus Manual

Consensus Protocol, 6 sessions, includes components of ERRT and other nightmare protocols.

Interventions

Exposure, Relaxation, and Rescripting Therapy

Brief cognitive behavioral treatment targeting trauma-related nightmares and sleep problems

Primary outcome measure

  • Nightmare Frequency Past Week [ Time Frame: up to 6 months followup ]

Central Contacts and Locations

Central contacts

Locations

Joanne L. Davis

Recruiting

Tulsa, Oklahoma, United States, 74104

Contacts

Principal Investigator:

Joanne L Davis, PhD

More Information

Sponsor

University of Tulsa

Last update posted

Jul 3, 2024

Last verified

Jul, 2024

Keywords

  • ERRT
  • Nightmares
  • Sleep
  • Trauma
  • PTSD

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Tulsa on 2024-07-03.